New Fund
New York-based Jefferson Life Sciences launched a new fund to invest in early-stage life sciences ventures focused on therapeutic platforms, rigorous science, and cutting-edge technologies at the frontier of human health.
Toronto-based BKR Capital secured a CA$20M first close to back...
Arlington, VA-based Sands Capital closed $1.1bn to back mid- to late-stage...
New York City-based Audeo Ventures secured $65M to invest in early-stage...
New York City-based Coefficient Capital closed $530M to back growth-stage...
Markham, Canada-based NordSpace Ventures launched an undisclosed-size fund...
Boston-based Cutting Horse closed a $75 million Fund I to back...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.
